(MENAFN- GlobeNewsWire - Nasdaq) Despite challenges like high production costs and uneven regulations, the region is set to become a hub for cutting-edge regenerative therapies. Nations like Japan, China, and South Korea are at the forefront, supported by collaborative efforts that bolster translational research and industrial scalability.

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell Sheet-based Gene Therapy Market: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Country - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets's offering.
The Asia-Pacific cell sheet-based gene therapy market is projected to reach $879 million by 2035 from $170.8 million in 2024, growing at a CAGR of 16.06% during the forecast period 2025-2035. Global regenerative medicine businesses aggressively extending their footprint and regional pioneers are major players in the APAC cell sheet-based gene therapy market. Leading companies in the field, including CellSeed Inc. (Japan) and J-TEC (Japan Tissue Engineering Co., Ltd.), have robust clinical pipelines and treatments that are ready for the market that target ocular, esophageal, and cardiac regeneration. These businesses profit from Japan's robust government backing for regenerative medicine and its innovative regulatory framework.

Temperature-responsive culture dishes are used by CellSeed Inc. to produce autologous cell sheet products, and J-TEC has created and marketed a number of autologous cell-based goods, such as skin and cartilage repair products. Scalable clinical deployment throughout Asia is supported by their integrated R&D and GMP-compliant production facilities.
In the meantime, further funding and collaborations are being made in nations like China and South Korea with the goal of commercializing gene-modified cell sheets for uncommon ocular and dermatological disorders. Through strategic partnerships between academia, government, and the commercial sector, biotech firms and institutions around the area are placing an emphasis on translational research and industrial scalability.
These advancements establish APAC as a competitive center for next-generation cell sheet-based gene treatments and demonstrate the region's expanding significance in fostering innovation for complicated epithelium and tissue regeneration therapies.
Market Segmentation

Segmentation 1: By Technology Type

• Cell sheet-based Engineering Techniques
  • Light-induced cell sheet technology
  • Temperature-Responsive Culture Surfaces
• Scaffold-Free Techniques
  • Layer-by-Layer Assembly
  • Other Techniques
• Gene Delivery Methods
  • Viral Vector-Based (e.g., Lentivirus, Adenovirus)
  • Non-Viral Vector-Based (e.g., Liposomes, Nanoparticles)
  • CRISPR/Cas9
  • Other Gene Delivery Methods

Segmentation 2: By Cell-Sheet Type

• Monolayer Cell-sheet Type
• Co-culture Cell-sheet Type
• Multilayered Cell-sheet Type
• Others

Segmentation 3: By Source Type

• Autologous
• Allogenic
• Stem-cell Derived

Segmentation 4: By Application

• Oncology
• Ophthalmology
• Genetic Disorders
• Cardiology
• Others

Segmentation 5: By End-User

• Hospitals and Clinics
• Research and Academic Institutions
• Biotech and Pharma Companies
• Others

Segmentation 6: By Region

• Asia-Pacific
• Japan
• India
• China
• Australia
• South Korea
• Rest-of-Asia-Pacific

Market Trends

• Rapid growth of the cell and gene therapy sector in the APAC region, supported by increasing clinical trials and commercial interest.
• Rising adoption of autologous therapies, especially for oncology, genetic, and regenerative applications.
• Strong innovation pipeline in countries like Japan, South Korea, and China for late-stage cell sheet therapies targeting cartilage, ocular, and skin tissues.

Market Drivers

• Growing burden of chronic, genetic, and age-related diseases is increasing demand for regenerative therapies.
• Supportive regulatory initiatives and fast-track approval mechanisms in key APAC countries are encouraging development and commercialization.
• Expanding public-private partnerships and infrastructure investments are boosting manufacturing capacity and clinical translation.

Market Challenges

• High production and operational costs for cell sheet-based therapies limit affordability and accessibility.
• Fragmented regulatory requirements across the region create hurdles for cross-border clinical and commercial integration.
• Shortage of skilled talent in advanced cell therapy manufacturing and quality control remains a key bottleneck.

Market Opportunities

• Integration of automation and AI-driven quality control to streamline production and reduce time to market.
• Expansion of contract manufacturing organizations (CMOs) and academic-industry collaborations to scale innovation.
• Increasing focus on personalized medicine and precision therapies is creating demand for novel cell-based platforms.

How can this report add value to an organization

• Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in APAC cell sheet-based gene therapy, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
• Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
• Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.
• Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines, ensuring organizations stay compliant and accelerate market entry for new APAC cell sheet-based gene therapy.
• Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Key Attributes

Report Attribute	Details
No. of Pages	51
Forecast Period	2025 - 2035
Estimated Market Value (USD) in 2025	$195.3 Million
Forecasted Market Value (USD) by 2035	$879 Million
Compound Annual Growth Rate	16%
Regions Covered	Asia-Pacific

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Asia-Pacific Cell Sheet-based Gene Therapy Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN31102025004107003653ID1110275984